Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Applied BioMath, LLC Announces Collaboration with Verseau Therapeutics for System Pharmacology Modeling in Oncology
Tuesday, August 04, 2020Applied BioMath wwwappliedbiomathcom the industryleader in applying systems pharmacology and mechanistic modeling simulation and analysis to derisk drug research and development announced their collaboration with Verseau Therapeutics for the developm...
G1 Therapeutics and Simcere Announce Exclusive License Agreement for Trilaciclib in Greater China
Tuesday, August 04, 2020G Therapeutics Inc a clinicalstage oncology company and Simcere Pharmaceutical Group a pharmaceutical company rapidly transitioning to an innovative and RDdriven company in China announced an exclusive license agreement for the development and commer...
Innovent Announces First Patient Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody in China
Monday, August 03, 2020Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes high quality medicines for the treatment of oncology metabolic autoimmune and other major diseases announced that the first patient has been s...
Sesen Bio announces an exclusive license agreement with Qilu Pharmaceutical for the development and commercialization of Vicineum™ in Greater China
Saturday, August 01, 2020Sesen Bio a latestage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer and Qilu Pharmaceutical a leading vertically integrated pharmaceutical company in China specializing in the manufacturing...
Oxford Biomedica Signs Three Year Clinical Supply Agreement with Axovant Gene Therapies for Manufacture and Supply of AXO-Lenti-PD
Saturday, August 01, 2020Oxford Biomedica plc a leading gene and cell therapy group announced that it has signed a three year Clinical Supply Agreement CSA with a whollyowned subsidiary of Axovant Gene Therapies Ltd The CSA builds on the worldwide license agreement signed be...
Harbour BioMed Announces Strategic Partnership with Viva Biotech to Collaborate on Incubating Innovative Biotech Start-ups
Friday, July 31, 2020Harbour BioMed HBM a global clinical stage biopharmaceutical company and Viva Biotech Shanghai Ltd Viva Biotech a worldleading structurebased drug discovery platform announced a strategic partnership under which both parties will collate their respec...
Piramal Pharma Solutions announces integrated development program with Bolt Biotherapeutics for immunostimulating antibody conjugates and sterile final fillings
Friday, July 31, 2020Piramal Pharma Solutions a leading contract development and manufacturing company CDMO announced that Bolt Biotherapeutics Bolt has both the ISAC drug substance BDC and the drug product for the ongoing phase clinical trial in cancer patients
UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer's Disease
Thursday, July 30, 2020UCB announced an agreement to enter into a worldwide exclusive license agreement with Roche and Genentech a member of the Roche Group for the global development and commercialization of UCB in Alzheimers Disease AD The transaction remains subject to...
Piramal Pharma Solutions Announces Integrated Development Program with Bolt Biotherapeutics for Immune-Stimulating Antibody Conjugates and Sterile Fill-Finish
Thursday, July 30, 2020Piramal Pharma Solutions a leading contract development and manufacturing organization CDMO announced that it is providing Bolt Biotherapeutics Bolt with the supply of both the BDC ISAC drug substance and the drug product for Bolts ongoing Phase cli...
Viva Biotech and Schrödinger Announce Strategic Collaboration to Generate and Interrogate Structures for Unsolved Targets
Wednesday, July 29, 2020Viva Biotech Holdingsand Schrdinger Inc announced a strategic collaboration to expand the reach of structurebased drug discovery by generating de novo crystal structures of highvalue targets
